Early vs. Late Readmission following Percutaneous Coronary Intervention: Predictors and Impact on Long-Term Outcomes

David Eccleston1, My-Ngan Duong2, Enayet Chowdhury2

  • 1Department of Medicine, University of Melbourne, Parkville, VIC 3050, Australia.

Insights

Unplanned readmissions after percutaneous coronary intervention (PCI), especially late ones, significantly increase the risk of major adverse cardiac events (MACE) and death within three years. Identifying high-risk patients post-PCI is crucial for better long-term outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Health Services Research

Background:

  • Readmissions within one year post-percutaneous coronary intervention (PCI) are common and pose a significant burden.
  • Long-term implications of these readmissions are not well understood.
  • This study investigates predictors and long-term outcomes of early versus late unplanned readmissions post-PCI.

Purpose of the Study:

  • To compare predictors of early (30-day) and late (31-day to 1-year) unplanned readmissions after PCI.
  • To assess the impact of unplanned readmission within the first year on long-term clinical outcomes (3-year follow-up).
  • To determine which readmission timing (early vs. late) poses a higher risk for adverse long-term outcomes.

Main Methods:

  • Analysis of 16,911 patients from the GenesisCare Cardiovascular Outcomes Registry (GCOR-PCI) (2008-2020).
  • Multivariate logistic regression to identify readmission predictors.
  • Cox proportional hazards regression to evaluate the impact of readmission on 3-year clinical outcomes (MACE, death).

Main Results:

  • 8.5% of patients (1422) experienced unplanned readmission within one year post-PCI.
  • Predictors included increasing age, female gender, prior CABG, renal impairment, and PCI for acute coronary syndromes.
  • Unplanned readmission within one year increased the risk of MACE (aHR 1.84) and death (aHR 1.86) at 3 years.
  • Late readmissions were more strongly associated with subsequent MACE and death between years 1 and 3.

Conclusions:

  • Unplanned readmissions within the first year post-PCI, particularly late ones, significantly elevate the risk of MACE and death at 3 years.
  • Late readmissions (after 30 days) are associated with a greater risk of adverse long-term outcomes.
  • Strategies to identify high-risk patients and implement interventions to reduce readmissions and subsequent adverse events are essential post-PCI.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
20
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
19
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
19
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
216
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
99
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
46